CIK: 0001782539 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value ($000): $160,556 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 225,688 | $71,433 | 44.5% | $121.31 | — | COM | 48576A100 |
| ILMN | ILLUMINA INC | 119,196 | $16,597 | 10.3% | $459.88 | -74.9% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $11,908 | 7.4% | $30.00 | -7.0% | COM | 413197104 |
| OCS | OCULIS HOLDING AG | 518,933 | $5,828 | 3.6% | $9.59 | +8.3% | ORDINARY SHARES | H5870P102 |
| — | EXSCIENTIA PLC | 859,892 | $5,512 | 3.4% | $18.64 | — | ADS | 30223G102 |
| — | ALPINE IMMUNE SCIENCES INC | 263,940 | $5,031 | 3.1% | $13.80 | — | COM | 02083G100 |
| XENE | XENON PHARMACEUTICALS INC | 106,680 | $4,914 | 3.1% | $18.43 | +91.7% | COM | 98420N105 |
| — | SOMALOGIC INC | 1,696,558 | $4,292 | 2.7% | $12.39 | — | CLASS A COM | 83444K105 |
| — | MERUS N V | 137,038 | $3,769 | 2.3% | $16.58 | — | COM | N5749R100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 304,277 | $3,727 | 2.3% | $13.67 | -33.5% | COM | 483497103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 96,100 | $2,837 | 1.8% | $30.26 | 0.0% | COM | 604749101 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 274,488 | $2,693 | 1.7% | $16.12 | -49.3% | COM | 69404D108 |
| ONC | BEIGENE LTD | 12,022 | $2,168 | 1.4% | $265.35 | — | SPONSORED ADR | 07725L102 |
| INCY | INCYTE CORP | 32,022 | $2,011 | 1.3% | $67.41 | -16.1% | COM | 45337C102 |
| GERN | GERON CORP | 913,550 | $1,928 | 1.2% | $2.64 | -26.2% | COM | 374163103 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 40,070 | $1,842 | 1.1% | $24.26 | +30.1% | COM | 76243J105 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $1,639 | 1.0% | $17.30 | -86.6% | COM CL A | 753018100 |
| REPL | REPLIMUNE GROUP INC | 184,739 | $1,557 | 1.0% | $18.17 | -36.2% | COM | 76029N106 |
| EXEL | EXELIXIS INC | 64,200 | $1,540 | 1.0% | $23.32 | -6.8% | COM | 30161Q104 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $1,307 | 0.8% | $15.46 | — | COM | 097702104 |
| — | AEROVATE THERAPEUTICS INC | 47,936 | $1,085 | 0.7% | $29.30 | — | COM | 008064107 |
| CABA | CABALETTA BIO INC | 47,150 | $1,070 | 0.7% | $11.21 | +49.9% | COM | 12674W109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 29,984 | $939 | 0.6% | $20.11 | +18.7% | COM | 004225108 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $741 | 0.5% | $9.39 | — | COM | 29384C108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $625 | 0.4% | $60.98 | -84.4% | COM | 00166B105 |
| BMEA | BIOMEA FUSION INC | 40,000 | $581 | 0.4% | $8.53 | +42.4% | COM | 09077A106 |
| ARGX | ARGENX SE | 1,430 | $544 | 0.3% | $355.40 | — | SPONSORED ADR | 04016X101 |
| — | ATHIRA PHARMA INC | 180,000 | $437 | 0.3% | $2.08 | — | COM | 04746L104 |
| — | EARGO INC | 147,904 | $383 | 0.2% | $4.68 | — | COM NEW | 270087208 |
| — | DBV TECHNOLOGIES S A | 370,950 | $353 | 0.2% | $5.33 | — | SPONSORED ADR | 23306J101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,615 | $349 | 0.2% | $85.74 | +3.2% | COM | 09061G101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,182 | $273 | 0.2% | $174.99 | 0.0% | COM | 558868105 |
| — | AFFIMED N V | 372,472 | $233 | 0.1% | $1.92 | — | COM | N01045108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 17,847 | $107 | 0.1% | $9.63 | -39.8% | COM | 09058V103 |
| GRTX | GALERA THERAPEUTICS INC | 613,223 | $89 | 0.1% | $8.13 | -98.1% | COM | 36338D108 |
| ABCL | ABCELLERA BIOLOGICS INC | 12,521 | $71 | 0.0% | $15.18 | -69.5% | COM | 00288U106 |
| KOD | KODIAK SCIENCES INC | 19,622 | $60 | 0.0% | $81.98 | -97.3% | COM | 50015M109 |
| — | FIBROGEN INC | 62,106 | $55 | 0.0% | $9.06 | — | COM | 31572Q808 |
| CERS | CERUS CORP | 14,172 | $31 | 0.0% | $5.54 | -70.2% | COM | 157085101 |